David McDonnell, MD

Trials

Studies that name David McDonnell, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:17 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT05303064 · Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

  Alkermes, Inc. · recruiting · Schizophrenia, Bipolar I Disorder · study director
• Ph3
  NCT04987229 · Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects

  Alkermes, Inc. · enrolling by invitation · Bipolar I Disorder, Schizophrenia · study director
• Ph1
  NCT04987658 · Phase 1 Study of OLZ/SAM in Pediatric Subjects With Bipolar I Disorder

  Alkermes, Inc. · completed · Bipolar I Disorder · study director
• Ph1
  NCT02922426 · An Insulin Sensitivity Study in Healthy Subjects

  Alkermes, Inc. · completed · Healthy Volunteers · study director
• Ph1
  NCT02804568 · A Phase 1 Safety Study in Adults With Schizophrenia

  Alkermes, Inc. · completed · Schizophrenia · study director
• Ph3
  NCT02634346 · A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)

  Alkermes, Inc. · completed · Schizophrenia · study director
• Ph2
  NCT02161718 · A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder

  Alkermes, Inc. · completed · Schizophrenia, Alcohol Use Disorder · study director

Grants

NIH projects from RePORTER, fetched 2026-11-12 07:17 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.